The Food and Drug Administration (FDA) has approved Aczone (dapsone; Almirall) Gel 7.5% for the topical treatment of acne vulgaris in patients aged ≥9 years. Previously, the treatment had been ...

Acne sufferers have a new option in their fight for smooth skin, and it's called Aczone. Here's what you need to know about the latest prescription drug: —It's a twice-dialy topical anti-inflammatory ...

The FDA has approved a new gel to treat acne. Aczone Gel 5%, made by QLT Inc., is approved to treat acne vulgaris. That's a common skin condition in which oil and dead skin cells clog the skin's pores ...

Add Yahoo as a preferred source to see more of our stories on Google. I once heard that hormonal acne tends to pick up when you hit your mid-20s. I don't know whether or not that’s actually true, but ...

ACZONE gel 5% is the only acne treatment to harness the potential of dapsone in a topical formulation to provide patients with a convenient and effective therapy. QLT owns worldwide marketing rights ...

After years of delay, topical dapsone gel 5% can now be prescribed for patients with mild to moderate acne, marking the first new chemically based drug treatment for acne in a decade. A sulfone drug, ...

Aczone was originally approved for sale on July 7, 2005. The Phase IV clinical trial of the product was performed to meet a post-approval commitment requested by the FDA. The purpose of this study was ...

IRVINE, Calif. Allergan sales, a wholly owned subsidiary of Allergan has completed its acquisition of Aczone gel 5 percent from QLT USA, according to published reports. Aczone is a topical treatment ...

Valeant Pharmaceuticals International, Inc. announced that its subsidiary, Biovail Laboratories International SRL has entered into an agreement to license the Canadian rights to Aczone (dapsone) gel 5 ...

Allergan announced the discontinuation of Aczone (dapsone) 5% 30g tubes. Allergan announced the discontinuation of Aczone (dapsone) 5% 30g tubes. The last ship date was March 31, 2016 and the ...